Trials / Completed
CompletedNCT05009875
Food Trial Evaluating the Efficacy of SBD111 Versus Placebo for the Clinical Dietary Management of the Metabolic Processes of Osteopenia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 286 (actual)
- Sponsor
- Solarea Bio, Inc · Industry
- Sex
- Female
- Age
- 45 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim of the trial is to determine if the SYNBIOTIC (prebiotic and probiotic), provided twice daily (capsule) will help support skeletal health in otherwise healthy postmenopausal women in the early years postmenopause (1-6 years post last menstruation) over a 12-month period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Medical Food SBD111 | Two capsules administered twice daily with morning and evening meals for 52 weeks |
| OTHER | Placebo | Two capsules administered twice daily with morning and evening meals for 52 weeks |
Timeline
- Start date
- 2021-12-15
- Primary completion
- 2024-07-17
- Completion
- 2024-08-01
- First posted
- 2021-08-18
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05009875. Inclusion in this directory is not an endorsement.